Outcome | Model 1 | Model 2 | Model 3 |
LVMI, g/m2.7 | −0.02882 | −0.00597 | 0.01003 |
LVMI2.7/EDV | −0.00157 | −0.00135 | −0.00108 |
RWT, ratio | 0.00014 | 0.00021 | 0.00030 |
LAVI, mL/m2 | 0.02431* | 0.03206* | 0.02840* |
EF, % | 0.01336 | 0.01369 | 0.00728 |
E/e′, ratio | −0.00843 | −0.00521 | 0.00086 |
GLS, % | −0.02085 | −0.01784 | −0.01333 |
GCS, % | −0.02332 | −0.02139 | −0.01778 |
SV, mL | −0.02847 | −0.03209 | −0.03206 |
RV peak S, cm/s | 0.01126 | 0.01249 | 0.01287 |
RV FAC, % | 0.00048 | 0.00051 | 0.00034 |
TRV Max, cm/s | 0.20262 | 0.18327 | 0.13431 |
TAPSE, cm | 0.0037* | 0.0040* | 0.0037* |
M1: demographics (age and sex).
M2: M1+systolic blood pressure, antihypertensive medication use.
M3: M2+other cardiovascular disease modifiable factors (diabetes mellitus, current smoking and continuous high-density lipoprotein).
Values are per 10 min/day light PA.
*P value <0.01.
E, peak early diastolic transmitral inflow velocities; EDV, end diastolic volume; e′, average of mitral early diastolic septal and lateral annular velocities; EF, ejection fraction; GCS, global circumferential strain; GLS, global longitudinal strain; LAVI, left atrial volume index; LVMI, left ventricular mass index; M, model; PA, physical activity; RV, right ventricular; RV FAC, RV fractional area change; RWT, relative valve thickness; SV, stroke vol; TAPSE, tricuspid annular plane systolic excursion; TRV, tricuspid regurgitation velocity.